Key Takeaways
Investors in SES AI Corporation (NYSE: SES) who suffered losses have until June 26, 2026, to move for lead plaintiff in a securities fraud class action lawsuit filed against the company.
The lawsuit, announced by law firms including The Law Offices of Frank R. Cruz and Glancy Prongay Wolke & Rotter LLP, alleges a series of misleading statements and failures to disclose material adverse facts about the company’s business and operations.
The class action covers investors who purchased SES AI securities between January 29, 2025, and March 4, 2026. The complaint alleges that SES AI overstated its business prospects, particularly concerning deals with companies that had limited or no operations. It also claims the company created an "appearance of revenue" by purchasing services in exchange for sales of its "Molecular Universe" AI product.
These issues culminated on March 4, 2026, when SES AI announced its fourth-quarter 2025 results and provided 2026 revenue guidance that was significantly below market expectations. The company also revealed it had been affected by material logistics constraints in late 2025. On this news, SES AI’s stock price fell $0.63, or 36.8 percent, to close at $1.08 per share on March 5, 2026, injuring investors. The lawsuit followed a December 2025 report from Wolfpack Research that had previously raised concerns about the company's customer relationships and revenue sources.
The legal action puts SES AI's financial reporting and operational disclosures under scrutiny. For investors, the June 26 deadline is the next key date, determining who will lead the litigation.
This article is for informational purposes only and does not constitute investment advice.
